No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
NICE recommends Pfizer’s Elrexfio® (Elranatamab) for NHS Cancer Drugs Fund
On 29 October 2024, UK’s National Institute for Health and Care Excellence (NICE) recommended Pfizer’s Elrexfio® (elranatamab) for use in the NHS’ Cancer Drugs Fund. The Cancer Drugs Fund provides funding for certain cancer medicines before they have been approved by...